FABP4-tastic 胰腺恒星细胞 Coddle KITL 支持固有的微环境瘤抑制
Aleksandr Dolskii1, Edna Cukierman1
1Cancer Signaling & Microenvironment Program, Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Lewis Katz School of Medicine, Temple Health, Philadelphia, Pennsylvania.
Cancer discovery
|April 30, 2025
概括
胰腺恒星细胞中KIT连接体 (KITL) 的损失通过削弱瘤抑制微环境驱动胰腺癌. 恢复KITL可能提供一种新疗法,以重新激活自然抗瘤防御.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 微环境研究 微环境研究
背景情况:
- 胰腺微环境在癌症发展中起着至关重要的作用.
- 自然微环境抑制瘤是一个长期存在的假设.
- 胰腺恒星细胞是胰腺微环境的关键组成部分.
研究的目的:
- 为了研究KIT连接体 (KITL) 在胰腺星状细胞表达的作用.
- 确定KITL损失对胰腺癌发展的影响.
- 探索针对胰腺瘤微环境的治疗策略.
主要方法:
- 在胰腺星状细胞中KITL表达的分析.
- 研究胰腺微环境中KITL损失的功能后果.
- 评估恢复KITL表达的潜力作为治疗方法.
主要成果:
- 胰腺恒星细胞中的KITL表达对于瘤抑制至关重要.
- 失去KITL可以使胰腺癌发展.
- 恢复KITL可以在胰腺纤维细胞中恢复瘤抑制功能.
结论:
- 胰腺恒星细胞中的KITL是一种关键的瘤抑制剂.
- 针对KITL提供了一种潜在的治疗策略,通过恢复微环境防御来治疗胰腺癌.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K


